Direct Endoscopic Necrosectomy Market Based on Diagnosis(Abdominal Scan, Abdominal Biopsy, Urine Test), Based on Patient Disorder(Walled-Off Necrosis (WON), Abdominal Pain, and Others), Based on Distribution Channel(Hospital Pharmacies, Surgical Store, Online Pharmacies), and by Region and Companies Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032.

Direct Endoscopic Necrosectomy Market Overview:

The Direct Endoscopic Necrosectomy Market is projected to reach a valuation of USD 16.00 Bn by 2032 at a CAGR of 5.1%, from USD 9.26 Bn in 2021.

The most recent corrective technology to be used in the management of Walled-Off Necrosis (WON) is direct Endoscopic Necrosectomy (DEN). Through the gastric or duodenal divider, necrotic tissue can be drained and endoscopically debrided.

Sanctum had a greater WON assurance rate (88% versus 45%) than endoscopic seepage alone, highlighting the importance of debridement of semi-strong necrotic material. DEN is a method used in a pit or restricted space; as a result, when the procedure is completed, the opening that was created to allow access to the pit shuts on its own, without the assistance of anyone else.

Considering the use of endoscopic necrosectomy is controlled by both the imaging results and the patient’s indications. For example, depending on an individual patient, the necrotic assortment could be changed through the stomach or duodenum.

Detailed Segmentation

The global direct endoscopic necrosectomy market is segmented on the basis of – Diagnosis, Patient Disorder, Distribution Channel, and Region. Represented below is a detailed segmental description:

Based on Diagnosis:

• Abdominal Scan
  • X-ray
  • Single Photon Emission Computed Tomography (SPECT)
  • Positron Emission Tomography (PET)
• Abdominal Biopsy
• Urine Test

Based on Patient Disorder:

• Walled-Off Necrosis (WON)
• Abdominal Pain
• Pancreatitis
• Pancreatic Ascites
• Abdominal Infection

Based on Distribution Channel:

• Hospital Pharmacies
• Surgical Store
• Online Pharmacies

Based on Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Market Dynamics

Drivers for the Global Direct Endoscopic Necrosectomy Market:

In both developed and developing countries, increasing life expectancy and surging healthcare spending are factors that are propelling the demand for direct endoscopic necrosectomy therapy products. These are variables that are expected to aid in the expansion of this target market.

Opportunity for the Global Direct Endoscopic Necrosectomy Market:

There is a probability that some necrotic debris will remain after using conventional methods, but this is not the case with the DEN method as this device allows for the suction of all necrotic derbies. With advancements in medical technology, there has been an increase in equipment innovations, with major industry players offering new equipment with improved capabilities. This factor is anticipated to create new opportunities for key market players.

Restraints for the Global Direct Endoscopic Necrosectomy Market:

With the DEN technique, there is a risk of substantial bleeding. Veins may be exposed and mistakenly cut while removing dead pancreas tissue inside the necrotic pit, resulting in enormous and difficult-to-control bleeding. This could hamper the adoption and subsequent revenue growth of this market.

Furthermore, due to a lack of awareness, several developed and developing countries have been gradually adopting direct endoscopic necrosectomy, which in turn may restrain this market in the process.

Key Developments

The year 2018:

• Interscope Inc. has received de novo authorization from the US Food and Drug Administration (FDA) to sell its EndoRotor System for direct endoscopic necrosectomy, minimally invasive treatment for walled-off pancreatic necrosis. In Europe, the EndoRotor System obtained the CE Mark for this indication in 2018.

For the XXXXX Market research study, the following years have been considered to estimate the market size: